139 related articles for article (PubMed ID: 3392658)
1. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
Diamond GL; Klotzbach JM; Stewart JR
J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
[TBL] [Abstract][Full Text] [Related]
2. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.
Klotzbach JM; Diamond GL
Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889
[TBL] [Abstract][Full Text] [Related]
3. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
4. In vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate.
Stewart JR; Diamond GL
Drug Metab Dispos; 1988; 16(2):189-95. PubMed ID: 2898331
[TBL] [Abstract][Full Text] [Related]
5. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
Cherian MG; Miles EF; Clarkson TW; Cox C
J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
Zhao-Fa X; Jing-Hua Y; Jia-Ming Y; Zhong-Wei Y
Wei Sheng Yan Jiu; 2005 Sep; 34(5):533-6. PubMed ID: 16329589
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous administration of sodium selenite and mercuric chloride decreases efficacy of DMSA and DMPS in mercury elimination in rats.
Juresa D; Blanusa M; Kostial K
Toxicol Lett; 2005 Jan; 155(1):97-102. PubMed ID: 15585364
[TBL] [Abstract][Full Text] [Related]
8. Effect of mercuric chloride on urinary excretion of free hydroxyproline.
Siddiqi NJ; Alhomida AS
Med Sci Monit; 2006 Mar; 12(3):BR95-101. PubMed ID: 16501418
[TBL] [Abstract][Full Text] [Related]
9. DMPS and N-acetylcysteine induced renal toxicity in mice exposed to mercury.
Brandão R; Santos FW; Zeni G; Rocha JB; Nogueira CW
Biometals; 2006 Aug; 19(4):389-98. PubMed ID: 16841248
[TBL] [Abstract][Full Text] [Related]
10. Determination and metabolism of dithiol chelating agents. III. Formation of oxidized metabolites of 2,3-dimercaptopropane-1-sulfonic acid in rabbit.
Maiorino RM; Weber GL; Aposhian HV
Drug Metab Dispos; 1988; 16(3):455-63. PubMed ID: 2900740
[TBL] [Abstract][Full Text] [Related]
11. Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.
Hurlbut KM; Maiorino RM; Mayersohn M; Dart RC; Bruce DC; Aposhian HV
J Pharmacol Exp Ther; 1994 Feb; 268(2):662-8. PubMed ID: 8113976
[TBL] [Abstract][Full Text] [Related]
12. Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides.
Maiorino RM; Xu ZF; Aposhian HV
J Pharmacol Exp Ther; 1996 Apr; 277(1):375-84. PubMed ID: 8613944
[TBL] [Abstract][Full Text] [Related]
13. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
Zalups RK; Gelein RM; Cernichiari E
J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
[TBL] [Abstract][Full Text] [Related]
14. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice.
Carvalho MC; Franco JL; Ghizoni H; Kobus K; Nazari EM; Rocha JB; Nogueira CW; Dafre AL; Müller YM; Farina M
Toxicology; 2007 Oct; 239(3):195-203. PubMed ID: 17703864
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular secretion of the alkanesulfonate 2,3-dimercapto-1-propanesulfonate.
Stewart JR; Diamond GL
Am J Physiol; 1987 May; 252(5 Pt 2):F800-10. PubMed ID: 3034073
[TBL] [Abstract][Full Text] [Related]
16. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Woods JS
Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants and metallothionein levels in mercury-treated mice.
Brandão R; Santos FW; Farina M; Zeni G; Bohrer D; Rocha JB; Nogueira CW
Cell Biol Toxicol; 2006 Nov; 22(6):429-38. PubMed ID: 16964587
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
[TBL] [Abstract][Full Text] [Related]
19. Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors.
Buchet JP; Lauwerys RR
Toxicology; 1989 Mar; 54(3):323-33. PubMed ID: 2539660
[TBL] [Abstract][Full Text] [Related]
20. Increased urinary excretion of carnitine and acylcarnitine by mercuric chloride is reversed by 2,3-dimercapto-1-propanesulfonic acid in rats.
Al-Madani WA; Siddiqi NJ; Alhomida AS; Khan HA; Arif IA; Kishore U
Int J Toxicol; 2010; 29(3):313-7. PubMed ID: 20448264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
